Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
Thomas Anderson, Rotem Petranker, Daniel Rosenbaum, et al.
Psychopharmacology (2019) Vol. 236, Iss. 2, pp. 731-740
Closed Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 563-567
Open Access | Times Cited: 237
A systematic study of microdosing psychedelics
Vince Polito, Richard J. Stevenson
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0211023-e0211023
Open Access | Times Cited: 176
Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti, Laura Kärtner, Allan Blemings, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 136
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Laura Kaertner, Michael B. Steinborn, Hannes Kettner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 108
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Federico Cavanna, Stephanie Müller, Laura Alethia de la Fuente, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 77
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field
Vince Polito, Paul Liknaitzky
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104706-104706
Open Access | Times Cited: 69
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raíssa Nóbrega de Almeida, Ana Cecília de Menezes Galvão, Flávia Santos da Silva, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 143
Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers
Anya K. Bershad, Scott T. Schepers, Michael P. Bremmer, et al.
Biological Psychiatry (2019) Vol. 86, Iss. 10, pp. 792-800
Open Access | Times Cited: 137
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3261-3270
Open Access | Times Cited: 136
Psychedelic microdosing benefits and challenges: an empirical codebook
Thomas Anderson, Rotem Petranker, Adam Christopher, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 97
Psychedelic Microdosing: A Subreddit Analysis
Toby Lea, Nicole Amada, Henrik Jungaberle
Journal of Psychoactive Drugs (2019) Vol. 52, Iss. 2, pp. 101-112
Closed Access | Times Cited: 88
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea, Nicole Amada, Henrik Jungaberle, et al.
International Journal of Drug Policy (2019) Vol. 75, pp. 102600-102600
Closed Access | Times Cited: 85
Psychedelic Microdosing: Prevalence and Subjective Effects
Lindsay P. Cameron, Angela Nazarian, David E. Olson
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 2, pp. 113-122
Open Access | Times Cited: 82
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 533-542
Open Access | Times Cited: 78
Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP
Ofir Livne, Dvora Shmulewitz, Claire Walsh, et al.
Addiction (2022) Vol. 117, Iss. 12, pp. 3099-3109
Open Access | Times Cited: 53
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J. Murphy, Rachael L. Sumner, William J. Evans, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 6, pp. 511-521
Open Access | Times Cited: 28
Clinical specificity profile for novel rapid acting antidepressant drugs
Mauro Scala, Giuseppe Fanelli, Diana De Ronchi, et al.
International Clinical Psychopharmacology (2023) Vol. 38, Iss. 5, pp. 297-328
Open Access | Times Cited: 25
The costs and benefits of psychedelics on cognition and mood
Ceyda Sayalı, Frederick S. Barrett
Neuron (2023) Vol. 111, Iss. 5, pp. 614-630
Open Access | Times Cited: 24
Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins
Antonin Rouaud, Abigail E. Calder, Gregor Hasler
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 217-224
Open Access | Times Cited: 12
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
Conor H. Murray, Joel Frohlich, Connor J. Haggarty, et al.
Neuropsychopharmacology (2024)
Closed Access | Times Cited: 11
Rapid-acting antidepressants
Jeffrey M. Witkin, Anna Martin, Lalit K. Golani, et al.
Advances in pharmacology (2019), pp. 47-96
Closed Access | Times Cited: 61
Narrative identity, rationality, and microdosing classic psychedelics
Megan Webb, Heith Copes, Peter S. Hendricks
International Journal of Drug Policy (2019) Vol. 70, pp. 33-39
Closed Access | Times Cited: 59
The therapeutic potential of microdosing psychedelics in depression
Kim P. C. Kuypers
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 58
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities
Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 6, pp. 612-622
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top